Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Other Non-Current Liabilities (2021 - 2025)

Korro Bio's Other Non-Current Liabilities history spans 5 years, with the latest figure at $1.5 million for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Liabilities rose 0.61% year-over-year to $1.5 million, compared with a TTM value of $1.5 million through Dec 2025, up 0.61%, and an annual FY2025 reading of $1.5 million, up 0.61% over the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $1.5 million at Korro Bio, down from $1.5 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $1.5 million in Q3 2025, with the low at $57000.0 in Q1 2022.
  • Average Other Non-Current Liabilities over 5 years is $811466.7, with a median of $893000.0 recorded in 2024.
  • Year-over-year, Other Non-Current Liabilities tumbled 82.56% in 2022 and then surged 113.67% in 2025.
  • Tracing KRRO's Other Non-Current Liabilities over 5 years: stood at $87000.0 in 2021, then dropped by 9.2% to $79000.0 in 2022, then skyrocketed by 1232.91% to $1.1 million in 2023, then skyrocketed by 39.79% to $1.5 million in 2024, then rose by 0.61% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Other Non-Current Liabilities are $1.5 million (Q4 2025), $1.5 million (Q3 2025), and $1.4 million (Q2 2025).